State of Alaska Department of Revenue’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-13,017
| Closed | -$278K | – | 1618 |
|
2023
Q2 | $278K | Sell |
13,017
-427
| -3% | -$9.12K | ﹤0.01% | 1556 |
|
2023
Q1 | $543K | Sell |
13,444
-124
| -0.9% | -$5.01K | 0.01% | 1324 |
|
2022
Q4 | $631K | Buy |
13,568
+80
| +0.6% | +$3.72K | 0.01% | 1237 |
|
2022
Q3 | $699K | Sell |
13,488
-457
| -3% | -$23.7K | 0.01% | 1118 |
|
2022
Q2 | $659K | Buy |
13,945
+1,250
| +10% | +$59.1K | 0.01% | 1209 |
|
2022
Q1 | $903K | Sell |
12,695
-45
| -0.4% | -$3.2K | 0.01% | 1086 |
|
2021
Q4 | $952K | Sell |
12,740
-385
| -3% | -$28.8K | 0.01% | 1116 |
|
2021
Q3 | $745K | Buy |
13,125
+690
| +6% | +$39.2K | 0.01% | 1263 |
|
2021
Q2 | $547K | Buy |
12,435
+282
| +2% | +$12.4K | 0.01% | 1407 |
|
2021
Q1 | $599K | Sell |
12,153
-1,750
| -13% | -$86.3K | 0.01% | 1337 |
|
2020
Q4 | $585K | Sell |
13,903
-2,800
| -17% | -$118K | 0.01% | 1273 |
|
2020
Q3 | $764K | Buy |
16,703
+1,420
| +9% | +$65K | 0.01% | 1017 |
|
2020
Q2 | $767K | Buy |
15,283
+460
| +3% | +$23.1K | 0.01% | 1021 |
|
2020
Q1 | $762K | Buy |
14,823
+2,755
| +23% | +$142K | 0.01% | 891 |
|
2019
Q4 | $745K | Sell |
12,068
-181
| -1% | -$11.2K | 0.01% | 1079 |
|
2019
Q3 | $735K | Buy |
12,249
+6,827
| +126% | +$410K | 0.01% | 1060 |
|
2019
Q2 | $457K | Buy |
5,422
+115
| +2% | +$9.69K | 0.01% | 1106 |
|
2019
Q1 | $506K | Buy |
5,307
+25
| +0.5% | +$2.38K | 0.01% | 1052 |
|
2018
Q4 | $374K | Buy |
5,282
+200
| +4% | +$14.2K | 0.01% | 1128 |
|
2018
Q3 | $434K | Buy |
5,082
+352
| +7% | +$30.1K | 0.01% | 1192 |
|
2018
Q2 | $548K | Buy |
4,730
+90
| +2% | +$10.4K | 0.01% | 1022 |
|
2018
Q1 | $375K | Buy |
4,640
+1,800
| +63% | +$145K | 0.01% | 1124 |
|
2017
Q4 | $166K | Buy |
2,840
+90
| +3% | +$5.26K | ﹤0.01% | 1362 |
|
2017
Q3 | $128K | Buy |
2,750
+20
| +0.7% | +$931 | 0.01% | 1124 |
|
2017
Q2 | $98K | Buy |
2,730
+1,190
| +77% | +$42.7K | 0.01% | 1111 |
|
2017
Q1 | $47K | Buy |
1,540
+40
| +3% | +$1.22K | ﹤0.01% | 1128 |
|
2016
Q4 | $50K | Buy |
+1,500
| New | +$50K | ﹤0.01% | 836 |
|